Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-08-03 RAAB MICHAEL President & CEO Shares withheld for taxes −150,343 $1.64 $247K 332,303
2021-08-03 RAAB MICHAEL President & CEO Exercise or conversion · Stock Option (Right to Buy) −267,892 0
2021-08-03 Jacobs Jeffrey W Chief Scientific Officer Exercise or conversion +10,000 $0.54 $5K 134,051
2021-08-03 Jacobs Jeffrey W Chief Scientific Officer Shares withheld for taxes −5,613 $1.64 $9K 128,438
2021-08-03 Jacobs Jeffrey W Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −10,000 0
2021-06-16 Bertrand William C JR Director Grant or award +8,891 83,549
2021-06-16 Bertrand William C JR Director Grant or award · Stock Option (Right to Buy) +32,765 32,765
2021-06-16 Bazemore Robert B Director Grant or award · Stock Option (Right to Buy) +32,765 32,765
2021-06-16 Rodgers Richard J Director Grant or award +9,917 87,527
2021-06-16 Rodgers Richard J Director Grant or award · Stock Option (Right to Buy) +32,765 32,765
2021-06-16 Cadoret-Manier Onaiza Director Grant or award · Stock Option (Right to Buy) +32,765 32,765
2021-06-16 Lundberg Jan M Director Grant or award +7,181 42,799
2021-06-16 Lundberg Jan M Director Grant or award · Stock Option (Right to Buy) +32,765 32,765
2021-06-16 Block Geoffrey A. Director Grant or award · Stock Option (Right to Buy) +32,765 32,765
2021-06-16 MOTT DAVID M Director Grant or award · Stock Option (Right to Buy) +32,765 32,765
2021-06-15 Jacobs Jeffrey W Chief Scientific Officer Exercise or conversion +7,500 $0.54 $4K 131,551
2021-06-15 Jacobs Jeffrey W Chief Scientific Officer Sale −7,500 $7.29 $55K 124,051
2021-06-15 Jacobs Jeffrey W Chief Scientific Officer Exercise or conversion · Stock Option (Right to Buy) −7,500 10,000
2021-05-28 Rosenbaum David P. Chief Development Officer Sale −3,062 $7.22 $22K 26,750
2021-05-20 Rosenbaum David P. Chief Development Officer Sale −612 $7.09 $4K 159,435

Page 30 of 38 · 756 trades